scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1031613871 |
P356 | DOI | 10.1080/13550280601009546 |
P698 | PubMed publication ID | 17162658 |
P50 | author | Javier S. Burgos | Q45402352 |
Esther Serrano-Saiz | Q79427128 | ||
P2093 | author name string | Fernando Valdivieso | |
Isabel Sastre | |||
P2860 | cites work | Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 |
Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47 | Q24562414 | ||
Inhibition of MHC class I is a virulence factor in herpes simplex virus infection of mice | Q24817190 | ||
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
Selectivity of MHC-encoded peptide transporters from human, mouse and rat | Q28249591 | ||
A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway | Q28266815 | ||
TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells | Q28589574 | ||
Herpes simplex virus type 1 infection via the bloodstream with apolipoprotein E dependence in the gonads is influenced by gender | Q33717104 | ||
Construction and properties of a viable herpes simplex virus 1 recombinant lacking coding sequences of the alpha 47 gene | Q33929730 | ||
TAP deficiency syndrome | Q33994458 | ||
Herpes simplex virus type 1, apolipoprotein E and Alzheimer' disease | Q34342133 | ||
Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous system | Q34360596 | ||
Hematogenous vertical transmission of herpes simplex virus type 1 in mice | Q34435095 | ||
Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen | Q34754320 | ||
Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses. | Q34840276 | ||
Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP | Q35899978 | ||
THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAINING | Q36266931 | ||
Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator | Q36362717 | ||
The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues | Q36377189 | ||
Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response. | Q36400254 | ||
Antigen recognition by class I-restricted T lymphocytes | Q38201551 | ||
Abeta production as consequence of cellular death of a human neuroblastoma overexpressing APP. | Q40536280 | ||
Neonatal herpes simplex infection in the absence of mucocutaneous lesions | Q40844864 | ||
Peptides naturally presented by MHC class I molecules | Q40898177 | ||
Herpes simplex virus turns off the TAP to evade host immunity | Q41338579 | ||
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes | Q41467257 | ||
HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. | Q41480540 | ||
Herpes simplex virus latent infection in the nervous system | Q41530799 | ||
Non-invasive bioluminescence imaging for monitoring herpes simplex virus type 1 hematogenous infection. | Q43996344 | ||
Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine | Q44460660 | ||
A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers. | Q45021493 | ||
ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1. | Q45710894 | ||
Neurotropic viruses and Alzheimer disease. Interaction of herpes simplex type 1 virus and apolipoprotein E in the etiology of the disease | Q45767261 | ||
Histological study of the progression of herpes simplex virus in mice | Q45803614 | ||
Herpes-simplex-virus infection after renal transplantation | Q45825855 | ||
Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type | Q45877119 | ||
A viral inhibitor of peptide transporters for antigen presentation | Q46243412 | ||
Influence of reagents formulation on real-time PCR parameters | Q77068230 | ||
P433 | issue | 6 | |
P921 | main subject | Herpes simplex virus type 1 | Q655331 |
P304 | page(s) | 420-427 | |
P577 | publication date | 2006-12-01 | |
P1433 | published in | Journal of NeuroVirology | Q6295640 |
P1476 | title | ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice | |
P478 | volume | 12 |
Q38933333 | An MHC class I immune evasion gene of Marek׳s disease virus. |
Q35040097 | Design and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice |
Q35172570 | Effects of thyroid hormone on HSV-1 gene regulation: implications in the control of viral latency and reactivation. |
Q34628398 | Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinology |
Q37253362 | HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion |
Q37135532 | Immunological control of herpes simplex virus infections |
Q28083232 | Viral inhibition of the transporter associated with antigen processing (TAP): a striking example of functional convergent evolution |